Trial Profile
A Randomised, Controlled, Assessor-blind, Parallel Groups, Multi-national, Multi-centre Trial Assessing the Dose-response Relationship of FE 999049 in Controlled Ovarian Stimulation in Women Undergoing an ART Programme
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Oct 2021
Price :
$35
*
At a glance
- Drugs Follitropin delta (Primary) ; Follitropin alfa
- Indications Endometriosis; Female infertility; Infertility
- Focus Therapeutic Use
- Sponsors Ferring Pharmaceuticals
- 21 Oct 2020 Results of pooled analysis from two studies including this study presented at the American Society for Reproductive Medicine Scientific Congress 2020.
- 21 Oct 2020 Results of post-hoc analysis from two clinical studies: NCT02309671 and NCT01426386 assessing ovarian response to different doses of follitropin delta between Japanese and non-Japanese population presented at the American Society for Reproductive Medicine Scientific Congress 2020
- 01 Mar 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.